Satsuma Pharmaceuticals, Inc. Financing Cash Flow
Satsuma Pharmaceuticals, Inc. reported Financing Cash Flow of $8.74 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-05-11
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $17.00K.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $9.70M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was -$478.00K.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was -$500.00K, a 100.67% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $8.74M, a 88.07% decline from fiscal 2021.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $73.28M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2020 was -$2.10M, a 101.47% decline from fiscal 2019.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $143.06M, a 1208.90% increase from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $9.72M derived: sum of 2 quarters · filed 2023-03-28 | $9.24M derived: sum of 3 quarters · filed 2023-03-28 | $8.74M 10-K · filed 2023-03-28 |
| 2022-09-30 | $9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $9.22M derived: sum of 2 quarters · filed 2022-11-03 | $8.72M 10-Q · filed 2022-11-03 | $8.28M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-06-30 | -$478.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$978.00K 10-Q · filed 2022-08-09 | -$1.42M derived: sum of 3 quarters · filed 2023-05-11 | -$1.92M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | -$500.00K 10-Q · filed 2023-05-11 | -$940.00K derived: sum of 2 quarters · filed 2023-05-11 | -$1.44M derived: sum of 3 quarters · filed 2023-05-11 | -$1.94M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$940.00K derived: sum of 2 quarters · filed 2023-03-28 | -$1.44M derived: sum of 3 quarters · filed 2023-03-28 | $73.28M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.00M derived: sum of 2 quarters · filed 2022-11-03 | $73.72M 10-Q · filed 2022-11-03 | $72.99M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $74.22M 10-Q · filed 2022-08-09 | $73.49M derived: sum of 3 quarters · filed 2022-08-09 | $73.07M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $74.72M 10-Q · filed 2022-05-10 | $73.99M derived: sum of 2 quarters · filed 2022-05-10 | $73.57M derived: sum of 3 quarters · filed 2022-05-10 | $73.11M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$733.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$1.15M derived: sum of 2 quarters · filed 2022-03-15 | -$1.61M derived: sum of 3 quarters · filed 2022-03-15 | -$2.10M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$418.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$879.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.37M 10-Q · filed 2021-11-09 | $5.00M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$950.00K 10-Q · filed 2021-08-10 | $5.42M derived: sum of 3 quarters · filed 2021-08-10 | $80.68M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$489.00K 10-Q · filed 2021-05-11 | $5.88M derived: sum of 2 quarters · filed 2021-05-11 | $81.14M derived: sum of 3 quarters · filed 2021-05-11 | $142.52M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $81.63M derived: sum of 2 quarters · filed 2021-03-25 | $143.01M derived: sum of 3 quarters · filed 2021-03-25 | $143.06M 10-K · filed 2021-03-25 |
| 2019-09-30 | $75.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $136.64M derived: sum of 2 quarters · filed 2020-11-10 | $136.69M 10-Q · filed 2020-11-10 | $141.64M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $61.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $61.43M 10-Q · filed 2020-08-11 | $66.38M derived: sum of 3 quarters · filed 2020-08-11 | |
| 2019-03-31 | $53.00K 10-Q · filed 2020-05-12 | $5.00M derived: sum of 2 quarters · filed 2020-05-12 | ||
| 2018-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $10.93M 10-K · filed 2020-03-10 | ||
| 2018-09-30 | $5.99M 10-Q · filed 2019-11-12 |